Baseline cardiac comorbidities based on cardiac events
| . | No cardiac events (N = 67) . | Cardiac events (N = 11) . | P value . |
|---|---|---|---|
| Hypertension | 34 (50.7%) | 6 (54.5%) | 1 |
| Hyperlipidemia | 12 (17.9%) | 3 (27.3%) | .751 |
| Diabetes mellitus | 6 (9.0%) | 1 (9.1%) | 1 |
| CAD (PCI/CABG) | 4 (6.0%) | 1 (9.1%) | 1 |
| CHF/cardiomyopathy | 2 (3.0%) | 1 (9.1%) | .896 |
| Stroke or TIA | 0 (0.0%) | 0 (0.0%) | 1 |
| COPD | 2 (3.0%) | 0 (0.0%) | 1 |
| OSA | 4 (6.0%) | 0 (0.0%) | .925 |
| Liver dysfunction | 0 (0.0%) | 0 (0.0%) | 1 |
| CKD stage I-III | 3 (4.5%) | 1 (9.1%) | 1 |
| CKD stage IV-V | 2 (3.0%) | 2 (18.2%) | .167 |
| Atrial arrhythmia | 8 (11.9%) | 2 (18.2%) | .93 |
| Ventricular arrhythmia | 1 (1.5%) | 0 (0.0%) | 1 |
| Smoking history | .642 | ||
| Past | 23 (34.3%) | 5 (45.5%) | |
| Never | 41 (61.2%) | 6 (54.5%) | |
| Current | 3 (4.5%) | 0 (0.0%) | |
| Rheumatologic disorder | 3 (4.5%) | 0 (0.0%) | 1 |
| . | No cardiac events (N = 67) . | Cardiac events (N = 11) . | P value . |
|---|---|---|---|
| Hypertension | 34 (50.7%) | 6 (54.5%) | 1 |
| Hyperlipidemia | 12 (17.9%) | 3 (27.3%) | .751 |
| Diabetes mellitus | 6 (9.0%) | 1 (9.1%) | 1 |
| CAD (PCI/CABG) | 4 (6.0%) | 1 (9.1%) | 1 |
| CHF/cardiomyopathy | 2 (3.0%) | 1 (9.1%) | .896 |
| Stroke or TIA | 0 (0.0%) | 0 (0.0%) | 1 |
| COPD | 2 (3.0%) | 0 (0.0%) | 1 |
| OSA | 4 (6.0%) | 0 (0.0%) | .925 |
| Liver dysfunction | 0 (0.0%) | 0 (0.0%) | 1 |
| CKD stage I-III | 3 (4.5%) | 1 (9.1%) | 1 |
| CKD stage IV-V | 2 (3.0%) | 2 (18.2%) | .167 |
| Atrial arrhythmia | 8 (11.9%) | 2 (18.2%) | .93 |
| Ventricular arrhythmia | 1 (1.5%) | 0 (0.0%) | 1 |
| Smoking history | .642 | ||
| Past | 23 (34.3%) | 5 (45.5%) | |
| Never | 41 (61.2%) | 6 (54.5%) | |
| Current | 3 (4.5%) | 0 (0.0%) | |
| Rheumatologic disorder | 3 (4.5%) | 0 (0.0%) | 1 |
Data are presented as a number (percentage).
Liver dysfunction defined as aspartate aminotransferaseor alanine aminotransferaselevels above twice the upper limit of normal.
CABG, coronary artery bypass graft; CAD, coronary artery disease; CHF, congestive heart failure; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; OSA, obstructive sleep apnea; PCI, percutaneous coronary intervention; TIA, transient ischemic attack.